TKPHF

Takeda Pharmaceutical Company

Exchange: PINK

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.

Current Price

$32.26

+0.00%

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Takeda Pharmaceutical Company (TKPHF) Dividends

Dividend Overview

Dividend Yield

—

Dividend / Share

—

Key Metrics

Market Cap

—

P/E Ratio

—

Forward P/E

—

EPS

—

PEG Ratio

—

Book Value

—

Dividend Yield

—

Profit Margin

—

ROE

—

Dividend History

Dividend Safety

TKPHF Dividend Analysis

Takeda Pharmaceutical Company (TKPHF) dividend analysis including yield, payout history, and sustainability metrics.

This page shows Takeda Pharmaceutical Company's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Takeda Pharmaceutical Company's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.